Injectable Drug Delivery by Management Forum (Mf)
In-Person Event
Mar 22 - 23, 2018
London, England, GB
OVERVIEW
Injectable Drug Delivery Course is organized by Management Forum (Mf) Ltd and will be held during Mar 22 - 23, 2018 at Le Meridien Piccadilly Hotel, London, England, United Kingdom.
The target audience for this medical event is Scientists and management in medical devices, pharmaceutical and biotechnology companies working in parenteral delivery. Personnel responsible for device programmes, product development, regulatory affairs and product lifecycle management will find this event beneficial. Previous delegates include: Directors, Senior Executives in R&D, Head of Device Departments, Combination Products Specialists, Drug Delivery Managers, Business Development Executives, Product Development Managers and those in Project Co-ordination and Marketing roles.
Conference Description :
The pharmaceutical industry and its main markets continue to change. Geopolitical changes influence healthcare industry funding models, demographic changes (in developed countries) increase the demand for healthcare and technology advancement opens up new opportunities. In drug delivery, we have witnessed a very significant transition. For many years oral tablets held the leading market positions. For example, at one time oral H2 receptor blockers were the blockbusters. These were replaced by proton pump inhibitors and then cholesterol-lowering drugs as the world’s biggest sellers. Today, depending upon which list you look at, around 9 of the world’s 12 best-selling drugs require a drug delivery device, as they are biologics for parental delivery or drugs for treatment of asthma, requiring an inhaler.
Injection devises to deliver the latest generation of drugs are evolving. First generation devices were typically mechanical and functioned only to get the drug into the body. Increasingly, in next-generation parenteral devices, the drug delivery device is recognized as the interface between the drug and the patient. It can offer many features and functions which improve usability, safety, efficacy, and compliance, plus many other functions beyond such as connectivity and diagnostics.
This conference looks at the latest trends, technologies and applications.
Benefits in Attending :
• Hear the latest trends in injectable drug delivery
• Know what’s in development for large volume and patch pump technology
• Keep abreast of market opportunities
• Understand the latest technologies using parenteral methods
• Clarify the importance of human factor studies and compliance monitoring
• Comply with the latest regulatory guidance and standards
• Meet other medical device and pharmaceutical professionals in the parenteral market
Fee Details :
IN EUR : Early Fee (Until Jan 12, 2018) : EUR 1819
Conference Fee (After Jan 12, 2018) : EUR 2099
IN USD : Early Fee (Until Jan 12, 2018) : USD 2027
Conference Fee (After Jan 12, 2018) : USD 2339
Additional details will be posted as soon as they are available.
The target audience for this medical event is Scientists and management in medical devices, pharmaceutical and biotechnology companies working in parenteral delivery. Personnel responsible for device programmes, product development, regulatory affairs and product lifecycle management will find this event beneficial. Previous delegates include: Directors, Senior Executives in R&D, Head of Device Departments, Combination Products Specialists, Drug Delivery Managers, Business Development Executives, Product Development Managers and those in Project Co-ordination and Marketing roles.
Conference Description :
The pharmaceutical industry and its main markets continue to change. Geopolitical changes influence healthcare industry funding models, demographic changes (in developed countries) increase the demand for healthcare and technology advancement opens up new opportunities. In drug delivery, we have witnessed a very significant transition. For many years oral tablets held the leading market positions. For example, at one time oral H2 receptor blockers were the blockbusters. These were replaced by proton pump inhibitors and then cholesterol-lowering drugs as the world’s biggest sellers. Today, depending upon which list you look at, around 9 of the world’s 12 best-selling drugs require a drug delivery device, as they are biologics for parental delivery or drugs for treatment of asthma, requiring an inhaler.
Injection devises to deliver the latest generation of drugs are evolving. First generation devices were typically mechanical and functioned only to get the drug into the body. Increasingly, in next-generation parenteral devices, the drug delivery device is recognized as the interface between the drug and the patient. It can offer many features and functions which improve usability, safety, efficacy, and compliance, plus many other functions beyond such as connectivity and diagnostics.
This conference looks at the latest trends, technologies and applications.
Benefits in Attending :
• Hear the latest trends in injectable drug delivery
• Know what’s in development for large volume and patch pump technology
• Keep abreast of market opportunities
• Understand the latest technologies using parenteral methods
• Clarify the importance of human factor studies and compliance monitoring
• Comply with the latest regulatory guidance and standards
• Meet other medical device and pharmaceutical professionals in the parenteral market
Fee Details :
IN EUR : Early Fee (Until Jan 12, 2018) : EUR 1819
Conference Fee (After Jan 12, 2018) : EUR 2099
IN USD : Early Fee (Until Jan 12, 2018) : USD 2027
Conference Fee (After Jan 12, 2018) : USD 2339
Additional details will be posted as soon as they are available.
KEY DATES
22 Mar, 2018
Event Start Date
23 Mar, 2018
Event End Date
SPECIALITIES
BiotechnologyPharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Le Meridien Piccadilly HotelRELATED CONFERENCES & LIVE WEBINARS
Quick Links